Pulmonary embolism in patients taking estrogen-progestagen oral contraceptives;Embolies pulmonaires sous contraception estro-progestative

Presse Medicale

Volumn 27, Issue 31, 1998, Pages 1566-1569

  Lauque, D ^a   Mazieres J ^a   Rouzaud, P ^a   Sie P ^a   Chamontin, B ^a   Carrie D ^a   Hermant, C ^a   Tubery, M ^a   Carles, P ^a  

^a CHU PURPAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ANTINUCLEAR ANTIBODY; CARDIOLIPIN ANTIBODY; DESOGESTREL; GESTAGEN; GESTODENE; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; HORMONAL CONTRACEPTION; HUMAN; LUNG EMBOLISM; ORAL DRUG ADMINISTRATION; PHLEBITIS; RISK ASSESSMENT; RISK FACTOR; THROMBOEMBOLISM;

ADULT; CONTRACEPTIVES, ORAL, COMBINED; CONTRACEPTIVES, ORAL, SYNTHETIC; ESTROGENS; FEMALE; HUMANS; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES;

EID: 0032541921     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Jordan WM. Pulmonary embolism. Lancet 1961 ; 2:1146-7.
2. Greenblatt DJ. A retrospective case-control study of diseases associated with oral contraceptive use. Am Heart J 1975 ; 89:677-8.
3. Porter JB, Hunter JR, Danielson DA, Jick H, Stergachis A. Oral contraceptives and nonfatal vascular disease : recent experience. Obstet Gynecol 1982 ; 59:299-302.
4. Vessey M, Mant D, Smith A, Yeates D. Oral contraceptives and venous thromboembolism : findings in a large prospective study. Br Med J 1986 ; 292:526.
5. Helmrich SP, Rosenberg L, Kaufman DW, Strom B, Shapiro S. Venous thromboembolism in relation to oral contraceptive use. Obstet Gynecol 1987 ; 69:91-5.
6. WHO Collaborative Study. Cardiovascular disease and use of oral contraceptives. WHO Bulletin OMS 1989 ; 67:417-23.
7. WHO Collaborative STtudy. Venous thromboembolic disease and combined oral contraceptives : results of international multicentre case-control study. Lancet 1995; 346:1575-82.
8. Spitzer WO, Lewis MA, Heinemann LA, Thorogood M, Mac Raek : on behalf of Transnational Research Group on Oral Contraceptives and the Health of Young Women. Third generation oral contraceptives and risk of venous thromboembolic disorders : an international case-control study. Br Med J 1996 ; 312:83-8.
9. Bloemenkamp KWM, Rosendaal FR, Helmerhorst FM, Buller HR, Vandenbrouke JP. Enhancement by factor V Leyden mutation of risk deep-vein thrombosis associated with oral contraceptives containing a third-generation progestogen. Lancet 1995 ; 346:1593-6.
10. Jick H, Jick SS, Gurewich V, Myers MW, Vasilakis C. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Lancet 1995 ; 346:1589-93.
11. Even P, Sors H, Safran D. Diagnostic des embolies pulmonaires. Analyse critique à propos de 338 observations. In «La maladie thrombo-embolique» Masson, Paris, p.45-94 (1981)
12. Bell WR, Simon TL, Demets DL. The clinical features of submassive and massive pulmonary emboli. Am J Med 1977 ; 62:355-60.
13. Rosing J, Tans G, Nicolaes GAF et al. Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second-and third-generation oral contraceptives. Br J Haematol 1997 ; 97:233-8.
14. Thorogood M, Mann J, Murphy M, Vessey M. Risk factors for fatal venous thromboembolism in young women: a case control study. Int J Epidemiol 1992 ; 21:48-52.
15. Vandenbrouke JP, Koster T, Briet E, Reitsma PH, Bertina RM, Rosendaal FR. Increased risk of venous thrombosis in oral contraceptive users who are cariers of factor V Leiden mutatuion. Lancet 1994; 344:1453-7.
16. Godsland IF, Crook D. Update on the metabolic effects of steroidal contraceptives and their relationship to cardiovascular disease risk. Am J Obstet Gynecol 1994 ; 170:1528-36.
17. WHO Collaborative Study. Effect of different progestogens in low estrogen oral contraceptives on venous thromboembolic disease. Lancet 1995 ; 346:1582-8.
18. Duranteau L, Logerot-Lebrun H. Contraception hormonale chez la femme. Méd Thérapeutique 1996 ; 2:453-70.
19. Gompel A, Chabbert-Buffet N, Poitout PH. Contraception des maladies à risque thromboembolique. Sang Thrombose Vaisseaux 1996 ; 8:101-5.